Cardiac septal defects constitute the majority ofcongenitalheartdisease(CHD)inhumansandfamilialrecurrenceisreportedtoexceed5%[Burnetal.,1998].Previously, mutations in GATA4 and NKX2.5 havebeendescribedtobepathogenicforostiumsecundumatrial septal defects (ASDII) and ventricular septaldefects(VSD)[Schottetal.,1998;Gargetal.,2003].Incontrast, CRELD1 and BMP4 constitute functionalcandidatesforregulardevelopmentoftheendocardialcushionandmutationsinthesegenescause atrioven-tricular septal defects (AVSD) in animal models andhumans [Jiao et al., 2003; Robinson et al., 2003]. Wehypothesizedthatmutationsin GATA4(NM_002052),NKX2.5 (NM_004387), CRELD1 (NM_015513), andBMP4(NM_001202)canbeidentifiedinalargecohortof patients withcongenital septal defects with a focusonASDII.Weanalyzedthecodingregionofthesefourgenesin205patientswithcongenitalseptaldefectsbysinglestrandedconformationalpolymorphism(SSCP)and sequencing. The patient cohort was assembledout of 110 patients with isolated ASDII. Of these,four subjects (3.6%) mentioned a familial history andformal segregation analysis of pedigrees suggestedan autosomal dominant inheritance. However, familyrelatives were not studied systematically. To thishomogenous ASDII patient cohort we added agroupof95individualswithdifferentcongenitalseptaldefects (60 ASDII, 22 perimembranous VSD, and13 AVSD) and concomitant minor cardiac malforma-tions (Aortic coarctation ¼CoA, persistent ductusarteriosus¼PDA or partial anomalous venousreturn¼PAPVR). These patients were included as asubgroup in a candidate gene approach reportedpreviously [Ozcelik et al., 2006]. All patients wereattending the Department for Congenital Heart Dis-ease, German Heart Institute Berlin (GHIB). Patientswith syndromic appearance and/or limb malforma-tions were excluded from the genetic study andcontrolsubjectswerematchedforethnicity.Thestudyprotocol was approved by the Institutional ReviewBoard of the GHIB and Charite´.A heterozygous c.1750C>T mutation of GATA4,which predicts p.A411V, was identified in a cauca-sian patient with multiperforated ASDII and PAPVR.After exclusion in 600 control chromosomes weconsideredthevarianttobeanovelASDIIassociatedmutation representing the fifth GATA4 mutationidentified in a patient with ASDII. The carrier was a73-year-old female with ASDII and sustained atrial
[1]
R. Dietz,et al.
Mutations in the EGF-CFC Gene Cryptic Are an Infrequent Cause of Congenital Heart Disease
,
2006,
Pediatric Cardiology.
[2]
G. Dbaibo,et al.
A novel mutation in the GATA4 gene in patients with Tetralogy of Fallot
,
2006,
Human mutation.
[3]
M. Furutani,et al.
Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect
,
2005,
American journal of medical genetics. Part A.
[4]
N. Niikawa,et al.
A novel GATA4 mutation completely segregated with atrial septal defect in a large Japanese family
,
2004,
Journal of Medical Genetics.
[5]
E. Goldmuntz,et al.
NKX2.5 mutations in patients with congenital heart disease.
,
2004,
Journal of the American College of Cardiology.
[6]
E. Goldmuntz,et al.
NKX2.5mutations in patients with congenital heart disease
,
2003
.
[7]
B. Hogan,et al.
An essential role of Bmp4 in the atrioventricular septation of the mouse heart.
,
2003,
Genes & development.
[8]
Jonathan C. Cohen,et al.
GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5
,
2003,
Nature.
[9]
C. Maslen,et al.
Missense mutations in CRELD1 are associated with cardiac atrioventricular septal defects.
,
2003,
American journal of human genetics.
[10]
J. Seidman,et al.
Congenital heart disease caused by mutations in the transcription factor NKX2-5.
,
1998,
Science.
[11]
P. Brennan,et al.
Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study
,
1998,
The Lancet.
[12]
E. Olson,et al.
Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis.
,
1997,
Genes & development.